Vericel Corp Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-07-30
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $9.20M.
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$5.34M.
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$16.12M, a 249.75% decline year-over-year.
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $10.77M.
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $15.04M.
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$1.82M, a 105.08% decline from fiscal 2023.
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $35.80M.
- Vericel Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$17.47M, a 150.34% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.27M 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | $9.20M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $15.04M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $15.35M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$4.52M 10-Q · filed 2026-07-30 | |||
| 2025-03-31 | -$5.34M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$1.82M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$16.52M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$11.01M 10-Q · filed 2025-07-31 | |||
| 2024-03-31 | -$16.12M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $35.80M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $32.49M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $19.75M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $10.77M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$17.47M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$3.33M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$6.30M 10-Q · filed 2023-08-02 | |||
| 2022-03-31 | -$6.70M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $34.71M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $20.93M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $18.14M 10-Q · filed 2022-08-03 | |||
| 2021-03-31 | $24.53M 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $6.85M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $16.74M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $28.82M 10-Q · filed 2021-08-04 | |||
| 2020-03-31 | $18.73M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $8.69M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $18.62M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$4.32M 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | $16.80M 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$8.58M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $26.43M 10-Q · filed 2019-11-05 | |||
| 2018-06-30 | $68.11M 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $3.88M 10-K · filed 2020-02-25 |